Annals of Oncology 3:513-526, 1992
© 1992 European Society for Medical Oncology
review-article |
Review: Retinoids in cancer prevention and therapy
Department of Clinical Research, Division of Oncology & Hematology, E. Hoffmann-La Roche Ltd Basel, Switzerland
Correspondence to: E. E.Holdener, M.D., Department of Clinical Research, Division of Oncology & Hematology, F. Hoffmann-La Roche Ltd, CH-4002 Basel, Switzerland
Retinoids are a class of compounds structurally related to vitamin A. In preclinical studies, all-trans retinoic acid (tretinoin), 13-cis retinoic acid (isotretinoin) and the aromatic retinoids etretinate and acitretin have preventive and therapeutic effects on carcinogen-induced premalignant and malignant lesions. Clinically, chemoprevention with isotretinoin and etretinate has been tested with some degree of success in such indications as basal cell carcinomas, squamous cell carcinomas, superficial bladder tumors and second primary tumors in patients with squamous cell carcinoma of the head and neck. Limited therapeutic success has also been achieved with retinoid treatment of precancerous and cancerous conditions of the skin, oral cavity, larynx, lung, bladder and vulva. Dramatic therapeutic effects have been observed in the treatment of acute promyelocytic leukemia with tretinoin, which leads to very high rate of complete remission. Excellent results were recently reported in the treatment of squamous cell carcinomas of the skin and cervix with a combination of isotretinoin and recombinant interferon alfa-2a (rIFN alfa-2a, Roferon®-A). The mechanism of action of retinoids is through modulation of cell proliferation and differentiation. Retinoids vary in their capacity to induce differentiation and to inhibit proliferation in a series of human transformed hematopoietic and epithelial cell lines. Some cytokines potentiate the retinoid-induced cell differentiation and act synergistically with retinoids to inhibit cell proliferation. The pattern of synergism is dependent upon the combination and tumor cell line tested. The discovery of nuclear retinoid receptors has contributed substantially to the understanding of the mechanism of action of retinoids at the molecular level. Further understanding of the molecular biology of retinoids is expected to contribute to a rational design of new retinoids in the future, which in turn may result in improvements in the prevention and therapy of cancer.
retinoids, cancer prevention, cancer therapy, cytokines, combination therapy, mechanism of action
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Orita, M. Hirose, S. Takahashi, K. Imaida, N. Ito, K. Shudo, H. Ohigashi, A. Murakami, and T. Shirai Modifying Effects of 1'-Acetoxychavicol Acetate (ACA) and the Novel Synthetic Retinoids Re-80, Am-580 and Am-55P in a Two-Stage Carcinogenesis Model in Female Rats Toxicol Pathol, February 1, 2004; 32(2): 250 - 257. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Karp, H. Pan, M. Zhang, D. J. Buckley, L. A. Schuler, and A. R. Buckley Identification of HRPAP20: A Novel Phosphoprotein that Enhances Growth and Survival in Hormone-Responsive Tumor Cells Cancer Res., February 1, 2004; 64(3): 1016 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Arnhold, H. Nau, S. Meyer, H. J. Rothkoetter, and A. D. Lampen Porcine Intestinal Metabolism of Excess Vitamin A Differs Following Vitamin A Supplementation and Liver Consumption J. Nutr., February 1, 2002; 132(2): 197 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sapi, M. B. Flick, K. Tartaro, S. Kim, Y. Rakhlin, S. Rodov, and B. M. Kacinski Effect of All-trans-Retinoic Acid on c-fms Proto-oncogene [Colony-stimulating Factor 1 (CSF-1) Receptor] Expression and CSF-1-induced Invasion and Anchorage-independent Growth of Human Breast Carcinoma Cells Cancer Res., November 1, 1999; 59(21): 5578 - 5585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Baier, T. Bondeva, R. Klinger, A. Bondev, and R. Wetzker Retinoic Acid Induces Selective Expression of Phosphoinositide 3-Kinase {{gamma}} in Myelomonocytic U937 Cells Cell Growth Differ., June 1, 1999; 10(6): 447 - 456. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. X. Qu, A. Dayal, M. A. Jensen, and B. G. W. Arnason All-trans Retinoic Acid Potentiates the Ability of Interferon Beta-1b to Augment Suppressor Cell Function in Multiple Sclerosis Arch Neurol, March 1, 1998; 55(3): 315 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Scita, N. Darwiche, E. Greenwald, M. Rosenberg, K. Politi, and L. M. De Luca Retinoic Acid Down-regulation of Fibronectin and Retinoic Acid Receptor alpha Proteins in NIH-3T3 Cells J. Biol. Chem., March 15, 1996; 271(11): 6502 - 6508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Fisher, M. Blumenberg, and M. Tomic-Canic Retinoid Receptors and Keratinocytes Critical Reviews in Oral Biology & Medicine, January 1, 1995; 6(4): 284 - 301. [Abstract] [Full Text] [PDF]
|
|